04.02 Abstract in Atti di convegno

04.02 Abstract in Atti di convegno: [2208] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 521 a 540 di 2.208

L’impatto della pandemia da COVID-19 sugli studenti universitari: Autoefficacia, ansia ed emozioni di riuscita

2021-01-01 Raccanello, D.; Vicentini, G.; Burro, R.

Bicultural identity integration and well-being among bicultural children: A longitudinal study

2021-01-01 Faccini, M.; Shamloo, S. E.; Raccanello, D.; Dusi, P.; Trifiletti, E.

Gold-based peptidomimetics for a targeted anticancer therapy

2011-01-01 Boscutti, G.; Nardon, C.; Ronconi, L.; Trevisan, A.; Formaggio, F.; Dou, Q. P.; DALLA VIA, L.; Fregona, D.

New lanthanide-based biosensors for the early detection of cancer antigens

2010-01-01 Nardon, C.; D., Fregona

New insights into the mechanism of action of the gold(III) dithiocarbamato complex AuL12: upstream inhibition of the ubiquitin-proteasome pathway and encapsulation in natural polysaccharides

2015-01-01 Tomasello, M. F.; Nardon, C.; Lanza, V.; Di Natale, G.; Salmaso, S.; Milardi, D.; Caliceti, P.; Fregona, D.; Pappalardo, G.

DESIGN AND DEVELOPMENT OF NEW METAL-BASED BIOSENSORS FOR THE EARLY DETECTION OF CANCER ANTIGENS IN ONCOLOGY

2009-01-01 Nardon, C.; Fregona, D.

20S proteasome inhibition by gold(III)-based antitumor agents: from in vitro and in vivo studies to X-ray crystallography

2015-01-01 Nardon, C.; Cendron, L.; Dou, Q. P.; Beck, P.; Groll, M.; Zanotti, G.; Fregona, D.

Cutting-edge anticancer agents: gold-based peptidomimetics targeting peptide transporters

2013-01-01 Nardon, Chiara; Q. P., Dou; Fregona, Dolores

Selective delivery of chemotherapeutics into tumor cells by use of targeting peptides

2012-01-01 A., Accardo; Nardon, Chiara; Boscutti, Giulia; D., Tesauro; I., Saccone; Fregona, Dolores; G., Morelli

Copper(II)- and Ruthenium(III)-based complexes with promising anticancer activity

2013-01-01 Nardon, C.; Adami, A.; Boscutti, G.; Marchiò, L.; Dalla Via, L.; Fregona, D.

In vitro and in vivo anticancer activity of recently patented gold-based peptidomimetics targeting peptide transporters

2012-01-01 Nardon, Chiara; Ping Dou, Q.; Fregona, Dolores

An excellence in medicinal inorganic chemistry: a portrait of the gold(I/III) complexes patented for therapeutic purposes from 2010 to 2015

2015-01-01 Pettenuzzo, N.; Brustolin, L.; Nardon, C.; Fregona, D.

Novel inorganic chemotherapeutics for cancer treatment

2015-01-01 Nardon, C.; Pettenuzzo, N.; Paro, M.; Fregona, D.

Design and development of new metal-based biosensors for the early detection of cancer antigens in oncology

2009-01-01 Nardon, C.; Ronconi, L.; Sitran, S.; Favaro, M.; Fregona, D.

A new strategy in chemotherapy: preliminary studies on Cu(II) complexes aimed at exploiting the enhanced copper uptake in malignancies

2012-01-01 Adami, A.; Dalla Via, L.; Imberti, C.; Nardon, C.; Marchiò, L.; Di Noto, V.; Fregona, D.

CCK8 receptor-mediated cancer treatment strategies in target therapy

2013-01-01 Nardon, Chiara; A., Accardo; Boscutti, Giulia; DI NOTO, Vito; DALLA VIA, Lisa; Fregona, Dolores; G., Morelli

New metal-based cancer-targeting chemotherapeutics

2015-01-01 Nardon, Chiara; Fregona, Dolores

Studio pilota sull’efficacia di una formulazione micellare contenente un complesso di Au(III) nel trattamento dell’artrite sperimentale da collagene nel topo

2015-01-01 Luisetto, R.; Nardon, C.; Lette de Oliveira, F.; Bassi, N.; Brustolin, L.; Pettenuzzo, N.; Fregona, D.; Punzi, L.; Doria, A.

Biological studies on Au(III) peptidomimetics about to enter Phase I clinical trials

2012-01-01 Nardon, C.; Ronconi, L.; Boscutti, G.; Paolini, M.; Formaggio, F.; Fregona, D.

Leading-edge gold(III) targeted chemotherapeutics in translational oncology

2015-01-01 Nardon, Chiara; Fregona, Dolores

Titolo	Data di pubblicazione	Autore(i)
L’impatto della pandemia da COVID-19 sugli studenti universitari: Autoefficacia, ansia ed emozioni di riuscita	1-gen-2021	Raccanello, D.; Vicentini, G.; Burro, R.
Bicultural identity integration and well-being among bicultural children: A longitudinal study	1-gen-2021	Faccini, M.; Shamloo, S. E.; Raccanello, D.; Dusi, P.; Trifiletti, E.
Gold-based peptidomimetics for a targeted anticancer therapy	1-gen-2011	Boscutti, G.; Nardon, C.; Ronconi, L.; Trevisan, A.; Formaggio, F.; Dou, Q. P.; DALLA VIA, L.; Fregona, D.
New lanthanide-based biosensors for the early detection of cancer antigens	1-gen-2010	Nardon, C.; D., Fregona
New insights into the mechanism of action of the gold(III) dithiocarbamato complex AuL12: upstream inhibition of the ubiquitin-proteasome pathway and encapsulation in natural polysaccharides	1-gen-2015	Tomasello, M. F.; Nardon, C.; Lanza, V.; Di Natale, G.; Salmaso, S.; Milardi, D.; Caliceti, P.; Fregona, D.; Pappalardo, G.
DESIGN AND DEVELOPMENT OF NEW METAL-BASED BIOSENSORS FOR THE EARLY DETECTION OF CANCER ANTIGENS IN ONCOLOGY	1-gen-2009	Nardon, C.; Fregona, D.
20S proteasome inhibition by gold(III)-based antitumor agents: from in vitro and in vivo studies to X-ray crystallography	1-gen-2015	Nardon, C.; Cendron, L.; Dou, Q. P.; Beck, P.; Groll, M.; Zanotti, G.; Fregona, D.
Cutting-edge anticancer agents: gold-based peptidomimetics targeting peptide transporters	1-gen-2013	Nardon, Chiara; Q. P., Dou; Fregona, Dolores
Selective delivery of chemotherapeutics into tumor cells by use of targeting peptides	1-gen-2012	A., Accardo; Nardon, Chiara; Boscutti, Giulia; D., Tesauro; I., Saccone; Fregona, Dolores; G., Morelli
Copper(II)- and Ruthenium(III)-based complexes with promising anticancer activity	1-gen-2013	Nardon, C.; Adami, A.; Boscutti, G.; Marchiò, L.; Dalla Via, L.; Fregona, D.
In vitro and in vivo anticancer activity of recently patented gold-based peptidomimetics targeting peptide transporters	1-gen-2012	Nardon, Chiara; Ping Dou, Q.; Fregona, Dolores
An excellence in medicinal inorganic chemistry: a portrait of the gold(I/III) complexes patented for therapeutic purposes from 2010 to 2015	1-gen-2015	Pettenuzzo, N.; Brustolin, L.; Nardon, C.; Fregona, D.
Novel inorganic chemotherapeutics for cancer treatment	1-gen-2015	Nardon, C.; Pettenuzzo, N.; Paro, M.; Fregona, D.
Design and development of new metal-based biosensors for the early detection of cancer antigens in oncology	1-gen-2009	Nardon, C.; Ronconi, L.; Sitran, S.; Favaro, M.; Fregona, D.
A new strategy in chemotherapy: preliminary studies on Cu(II) complexes aimed at exploiting the enhanced copper uptake in malignancies	1-gen-2012	Adami, A.; Dalla Via, L.; Imberti, C.; Nardon, C.; Marchiò, L.; Di Noto, V.; Fregona, D.
CCK8 receptor-mediated cancer treatment strategies in target therapy	1-gen-2013	Nardon, Chiara; A., Accardo; Boscutti, Giulia; DI NOTO, Vito; DALLA VIA, Lisa; Fregona, Dolores; G., Morelli
New metal-based cancer-targeting chemotherapeutics	1-gen-2015	Nardon, Chiara; Fregona, Dolores
Studio pilota sull’efficacia di una formulazione micellare contenente un complesso di Au(III) nel trattamento dell’artrite sperimentale da collagene nel topo	1-gen-2015	Luisetto, R.; Nardon, C.; Lette de Oliveira, F.; Bassi, N.; Brustolin, L.; Pettenuzzo, N.; Fregona, D.; Punzi, L.; Doria, A.
Biological studies on Au(III) peptidomimetics about to enter Phase I clinical trials	1-gen-2012	Nardon, C.; Ronconi, L.; Boscutti, G.; Paolini, M.; Formaggio, F.; Fregona, D.
Leading-edge gold(III) targeted chemotherapeutics in translational oncology	1-gen-2015	Nardon, Chiara; Fregona, Dolores

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 521 a 540 di 2.208

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext1910
open188
restricted61
reserved49

CATALOGO DEI PRODOTTI DELLA RICERCA